Everything below concerns mass spectrometry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-30. Numbers and descriptions here follow the published literature rather than marketing material.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
=== Measures of success === Success of liquid–liquid extraction is measured through separation factors and decontamination factors. The best way to understand the success of an extraction column is through the liquid–liquid equilibrium (LLE) data set. The data set can then be converted into a curve to determine the steady state partitioning behavior of the solute between the two phases. The y-axis is the concentration of solute in the extract (solvent) phase, and the x-axis is the concentration of the solute in the raffinate phase. From here, one can determine steps for optimization of the process.
==== AICAR transformylase ==== AICAR transformylase requires the coenzyme N10-formyltetrahydrofolate (N10-formyl-THF) as the formyl donor for the formylation of AICAR to FAICAR. However, AICAR transformylase and GAR transformylase do not share a high sequence similarity or structural homology.
During his 2024 reelection campaign, the Electoral Courts permitted the removal of graffiti that portrayed Melo, partially submerged by flooding. The mural, dubbed Chimelo, was made by the artist Filipe Harp, and was based on an illustration by Bruno Ortiz Monllor. Chimelo was sprayed onto the wall of a cultural center in the Cidade Baixa neighborhood. In a decision rendered on 15 August, Judge Patrícia Hochheim Thomé judged that the panel had been framed as electoral propaganda in the locality or loosely covered by legislation. She ruled that the mural be removed within 24 hours, or be faced with a fine of $5,000 real in case of insubordination, and was rapidly covered up. In September of that year, however, the state Regional Electoral Court (TRE) reauthorized the reproduction of the mural. The art was understood by the Public Electoral Ministry (MPE) was to be interpreted and treated as elaborate art by a citizen who was not running as a candidate. Desembargador Nilton Tavares da Silva agreed with the notion and voted for the mural's authorization. The decision was supported by the court in a unanimous decision.
Sources: en.wikipedia.org
We are the new group Mata Zetas (Zeta Killers) and we are against kidnapping and extortion, and we will fight them in all states for a cleaner Mexico. These murdered men were then linked to individuals who had been shown in a video on YouTube while being interviewed by masked men armed with assault rifles. A number of videos online confirmed the existence of the Jalisco New Generation Cartel, which was dedicated at that time to kill Gulf Cartel and Zeta members alike. In the interrogation videos done by the Mata Zetas, the captured cartel members confessed their criminal activities and gave out the names of police commanders and politicians who provided them with protection. According to Terra Networks, the government agency of the SEIDO received a phone call on 1 July 2009 from an unidentified man who said that the cartel members of Los Zetas were going to be "kidnapped and eliminated" from Cancún and Veracruz.
== Awards and recognition == Eberlin was named among the Forbes "30 Under 30" list in 2015. She won the Marion Milligan Mason Award of the American Association for the Advancement of Science in 2016. The award is given every two years to promising young female researchers in chemistry. She won the MacArthur "Genius" Fellowship from the John D. and Catherine T. MacArthur Foundation in 2018 for her research on the use of mass spectrometry "to differentiate more quickly and accurately diseased from healthy tissues during surgery". She is the first UT Austin professor to win MacArthur grant this century. The award consists of a $625,000 no-strings-attached grant. According to the foundation, this award goes to "extraordinarily talented and creative individuals as an investment in their potential". She also won the Moore Inventor Fellowship in 2018. She received the 2020 Curt Brunnée Award from the International Mass Spectrometry Foundation. She was named on the Power List by the Analytical Scientist in 2014, 2018, 2019, 2021, 2022, 2023, and 2024. She received the 2024 Norman Hackerman Award from the Welch Foundation and the Biemann Medal from the American Society for Mass Spectrometry in 2025.
changes, most probably the behaviors of people in the community have changed from their normal patterns before the outbreak, or the disease has mutated to a new form. Costive massive detection and isolation of susceptible close contacts have effects on reducing
=== June === 1 June – Mark Rocket becomes the first New Zealander to reach space after flying on the Blue Origin NS-32 suborbital spaceflight. 2 June: The 2025 King's Birthday Honours are announced. Notable recipients include comedian Dai Henwood, Suzy Cato, Louise Wallace and Jude Dobson. Australian mining company Siren Gold is granted a permit to explore gold and antimony in the Marlborough Sounds. 3 June: Online retailer Trade Me acquires a 50 percent stake in media company Stuff's Stuff Digital division. Former National Party minister and MP Steven Joyce becomes chair of media company NZME's board while Canadian billionaire Jim Grenon becomes the company's director following a board meeting. The 90,000 Pawprint Petition calling for a ban on the public sale of fireworks is presented to the New Zealand Parliament. WorkSafe New Zealand launches a new road cone online tipline. The Kaipara District Council confirms that Dargaville's water supply pipeline is fully repaired following four days of disruptions caused by four separate ruptures. 4 June – The navigation radar of HMAS Canberra's accidentally disrupts Internet service and radio signals over a large area spanning Taranaki in the North Island to the Marlborough District in the South Island. When made aware, Canberra's crew changed her systems to non-interfering frequencies. 5 June: Police charged three individuals with manslaughter in relation to the Loafers Lodge fire.
Sources: en.wikipedia.org
=== Municipal politics (2025–2026) === On September 17, 2025, Findlay became the advisory board chair of the Conservative Electors Association, a newly formed municipal party in British Columbia. Her role was to help with candidate recruitment and policy development. In February 2026, Findlay was involved in a launch event for the Conservative Electors Association, where they announced the slate of candidates for the 2026 Surrey municipal election.
The three substrates of this enzyme are glutathione amide disulfide, reduced nicotinamide adenine dinucleotide (NADH), and a proton. Its products are glutathione amide and oxidised NAD+. Glutathione amide reductase is a dimeric flavoprotein (FAD).
=== GABAB receptor agonists === The GABAB receptor agonist sodium oxybate (SXB; Xyrem), also known as γ-hydroxybutyrate (GHB), has hypnotic and sleep-improving effects. It robustly increases slow wave sleep (deep sleep), decreases sleep fragmentation, and improves rapid eye movement (REM) sleep consolidation, all whilst preserving physiological sleep architecture. The drug is approved and clinically used in the treatment of narcolepsy and excessive daytime sleepiness (EDS). Narcolepsy is associated with poor sleep, and sodium oxybate improves sleep quality and stability in the condition, in turn reducing symptoms like daytime sleepiness and cataplexy. The robust enhancement of slow wave sleep by sodium oxybate is unusual and potentially advantageous relative to other hypnotics. In addition, unlike the case of many other hypnotics, tolerance does not appear to develop to the hypnotic effects of sodium oxybate. Sodium oxybate also completed formal clinical development for fibromyalgia. This condition has very high rates of non-restorative sleep (unrefreshing sleep) that may be directly involved in its symptoms. Sodium oxybate improved sleep in fibromyalgia and showed moderate effectiveness in treating multiple symptoms across the condition including pain and fatigue. However, despite its effectiveness, sodium oxybate was ultimately not approved for treatment of fibromyalgia owing mostly to concerns about possible misuse.
=== Utilization of templates === One of the most significant character of sequence-controlled biosynthesis against other chemical synthetic methods is that the biomolecules (including DNA and RNA) can initiate their polymerization using highly programmed templates. Hence, biosynthetic methods, like PCR, are still considered one of the most cogent manner to develop sequence-controlled polymers.
== Cause == FECD is a degenerative disease of the corneal endothelium with accumulation of focal outgrowths called guttae (meaning a drop-like appearance) and thickening of Descemet's membrane, leading to corneal edema and loss of vision. The corneal endothelial cell layer and its basement membrane (Descemet's membrane) act as a barrier to hydration of the corneal stroma by aqueous humor and are "pump" cells of the cornea that function to maintain hydration of the cornea at a specific level that maintains corneal stromal clarity through precise spatial arrangement of collagen fibers. In FED, Descemet's membrane is grossly thickened with accumulation of abnormal wide-spaced collagen and numerous guttae. Corneal endothelial cells in end-stage FED are reduced in number and appear attenuated, causing progressive stromal edema (swelling). Progressive endothelial cell loss causes relative influx of aqueous humor into the cornea, leading to swelling (corneal stromal edema), which results in blurred vision. Eventually, the epithelium also becomes edematous, resulting in more severe visual impairment. Focal blisters of epithelial edema ("bullae") may be particularly painful when they burst. The inheritance of FECD is complex and polymorphic such that although inheritance is autosomal dominant there are genetic and environmental modifiers that determine the degree to which members of the same family express the disease. There is reasonable evidence of associations between transcription factor 4 (TCF4) genetic polymorphisms and risk of Fuchs' endothelial dystrophy (FED).
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
Mass spectrometry establishes whether the observed molecular weight matches the calculated sequence mass. Chromatographic retention and fragment mapping add further confidence about sequence and composition. A single technique alone is rarely treated as sufficient evidence of identity.